DUBLIN--(BUSINESS WIRE )--The "Oxygen Long Term COVID-19 Treatments Address Pulmonary Arterial Vascular Degeneration: Treatment with Portable Oxygen Concentrators" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering.
Exercise intolerance is responsive to intermittent supplemental oxygen. Oxygen treatments represent next generation automation of helping people who are challenged by exercise. The oxygen market has a CAGR of 17.4%.
Exercise intolerance is a side effect of long term COVID, often a diagnosis for those who have unusual fatigue who have been tested by a physician and determined to have no verifiable signs of disease, yet they are still disabled. The problem is frequently a lack of oxygen that impacts the blood flow between organs, between the heart and the lungs.
Until now, the diagnosis has been hard to achieve. It has been discovered that the spikes on the virus do subtle vascular damage that is only apparent when the person exercise strenuously. Mostly it appears that the subtle damage can be repaired with diet, exercise, oxygen, and good nutrition. This is expected to further stimulate oxygen markets as studies demonstrate the efficacy of various treatment regimes.
Exercise Intolerance - Oxygen Concentrator Executive Summary
1. Exercise Intolerance: Portable Oxygen Concentrator Market Description and Market Dynamics
1.1 Diagnosing and Treating People with Fatigue, People Who Are Challenged by Exercise
1.2 Pulmonary Arterial Hypertension (PAH), High Blood Pressure in the Lungs, Characterized by Exercise Intolerance
1.5 Portable Oxygen Concentrator for Exercise Intolerance
2 Oxygen Long Term Treatment Market Driving Forces
2.2 Exercise Intolerance Cardio-Pulmonary Portable Oxygen Concentrator Market Shares:
2.4 Research White Paper: Supplemental Oxygen
2.8 Exercise Intolerance Equipment Market Forecasts
2.9 Worldwide Patients on Oxygen Market Forecasts, Worldwide, 2021-2028
2.11 Portable Oxygen Concentrator Regional Market Analysis
3. Exercise Intolerance Portable Oxygen Concentrator for Heart Failure Market Dynamics
3.1 Chronic Fatigue and Long Term Covid
3.3 Chronic Fatigue Syndrome Recognized as a Disability Qualifying for Reimbursement
4.3.1 Comparison of Conventional Oxygen Concentrators and Advanced Technology Fractionators
5 Portable Oxygen Equipment Company Description
5.6 Foshan Keyhub Electronic Industries Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/w5yipj
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900